Dr. Rosana Esteller is a pioneer in neurotechnology and was a key architect of the world’s first closed-loop brain-implantable neuromodulation device for epilepsy, now commercially available and powered by biomarker detection algorithms she developed. She co-founded IntelliMedix Inc., which merged with NeuroPace, where her pivotal contributions in device development and clinical studies helped enable pre-market approval for this groundbreaking technology.
She received her M.Sc. in Biomedical Engineering from Simón Bolívar University and her Ph.D. in Electrical Engineering from the Georgia Institute of Technology. In 2016, she joined Boston Scientific, where she advanced through leadership roles culminating in Associate Director and Scientific Fellow in R&D. There, she continued to drive innovation in neuromodulation therapies. With over 27 years of industry experience, she has led transformative medical device programs from concept to market, invented over 100 patents, and contributed extensively to the field through peer-reviewed publications, book chapters, and conference presentations. She also secured major research funding, including a recent $7.2M NIH award as Boston Scientific PI.
She is now a Professor in the Department of Biomedical Engineering at the University of Minnesota and a MnDrive Neuromodulation Scholar, where she leads research on intelligent neurotechnologies that integrate sensing, biomarker discovery, modeling, closed-loop control, and rapid prototyping to modulate the nervous system and restore or enhance physiological and cognitive function. Her team advances innovations from proof-of-concept to clinical translation with the goal of achieving real-world impact and adoption.
